Dr Choi was able to attend the meeting after receiving the Australian Vascular Biology Society (AVBS) Travel Award.

He was joined by Head of Centenary’s Cell Signalling Laboratory, Dr Xiangjian (XJ) Zheng.

The pair presented their most recent study, published in the scientific journal Science Advances, which identified a cancer drug as a potential treatment option for Cerebral Cavernous Malformations (CCM) – a leading cause of stroke in young people.